BDR Pharmaceuticals Internationals Overview
- Year Founded
-
2003
- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
1
- Investments
-
1
BDR Pharmaceuticals Internationals General Information
Description
Manufacturer of active pharmaceutical ingredients (APIs) intended to serve the pharmaceutical Industry. The company provides a wide range of products that include therapeutic areas of oncology, critical care, neurology, gynecology and covid-19 drugs, thereby providing affordable medicines available to the masses without compromising on quality.
Contact Information
Website
www.bdrpharma.comCorporate Office
- 407/408, Sharda Chambers
- New Marine Lines
- Mumbai, Maharashtra 400020
- India
Corporate Office
- 407/408, Sharda Chambers
- New Marine Lines
- Mumbai, Maharashtra 400020
- India
BDR Pharmaceuticals Internationals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BDR Pharmaceuticals Internationals Comparisons
Industry
Financing
Details
BDR Pharmaceuticals Internationals Competitors (18)
One of BDR Pharmaceuticals Internationals’s 18 competitors is Encube Ethicals, a Private Equity-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Encube Ethicals | Private Equity-Backed | Mumbai, India | ||||
| Farbe Firma Pvt. | Corporation | Ankleshwar, India | ||||
| Glenmark Farmacêutica | Corporation | Sao Paulo, Brazil | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India |
BDR Pharmaceuticals Internationals Patents
BDR Pharmaceuticals Internationals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025238661-A1 | An improved process for the preparation of osimertinib | Pending | 17-May-2024 | ||
| AU-2025207799-A1 | A process for the preparation of relugolix | Pending | 12-Jan-2024 | ||
| WO-2025150064-A1 | A process for the preparation of relugolix | Inactive | 12-Jan-2024 | ||
| AU-2023250273-A1 | Novel process and intermediate for the preparation of apalutamide | Pending | 08-Apr-2022 | ||
| EP-4504715-A1 | Novel process and intermediate for the preparation of apalutamide | Pending | 08-Apr-2022 | C07D401/04 |
BDR Pharmaceuticals Internationals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BDR Pharmaceuticals Internationals Investments (1)
BDR Pharmaceuticals Internationals’s most recent deal was a Buyout/LBO with Acme Generics (Oral Solid Formulations Business). The deal was made on 09-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Acme Generics (Oral Solid Formulations Business) | 09-Nov-2026 | Buyout/LBO | Pharmaceuticals |
BDR Pharmaceuticals Internationals FAQs
-
When was BDR Pharmaceuticals Internationals founded?
BDR Pharmaceuticals Internationals was founded in 2003.
-
Where is BDR Pharmaceuticals Internationals headquartered?
BDR Pharmaceuticals Internationals is headquartered in Mumbai, India.
-
What industry is BDR Pharmaceuticals Internationals in?
BDR Pharmaceuticals Internationals’s primary industry is Pharmaceuticals.
-
Is BDR Pharmaceuticals Internationals a private or public company?
BDR Pharmaceuticals Internationals is a Private company.
-
What is the current valuation of BDR Pharmaceuticals Internationals?
The current valuation of BDR Pharmaceuticals Internationals is .
-
What is BDR Pharmaceuticals Internationals’s current revenue?
The current revenue for BDR Pharmaceuticals Internationals is .
-
How much funding has BDR Pharmaceuticals Internationals raised over time?
BDR Pharmaceuticals Internationals has raised $90.1M.
-
Who are BDR Pharmaceuticals Internationals’s investors?
Balkrishna Industries, Bennett, Coleman and Company, HCL Capital, Multiples Alternate Asset Management, and QRG Investments and Holdings are 5 of 7 investors who have invested in BDR Pharmaceuticals Internationals.
-
Who are BDR Pharmaceuticals Internationals’s competitors?
Encube Ethicals, Farbe Firma Pvt., Glenmark Farmacêutica, Pfizer (Vienna), and Intas Pharmaceuticals are some of the 18 competitors of BDR Pharmaceuticals Internationals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process